Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says Martin Whitaker has resigned as chief executive officer and as a member of the board, effective immediately. Chief Financial Officer Richard Bungay acts as interim CEO.
"The board has initiated an international search for a new CEO with strong commercial credentials," the firm adds.
Current stock price: 15.56 pence, down 2.8% on Monday
12-month change: down 80%
By Tom Budszus; tombudszus@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.